# UAB Alzheimer's Disease Center Core Cohort - Tau Imaging Substudy

> **NCT03809351** · PHASE1 · RECRUITING · sponsor: **University of Alabama at Birmingham** · enrollment: 160 (estimated)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** [F-18]AV-1451-PET

## Key facts

- **NCT ID:** NCT03809351
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-07-08
- **Primary completion:** 2028-07
- **Final completion:** 2028-07
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2025-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03809351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03809351, "UAB Alzheimer's Disease Center Core Cohort - Tau Imaging Substudy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03809351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*